Form 4 for AARD Aardvark Therapeutics, Inc.
Accepted 2025-12-12 00:00:00 ET · period of report 2025-12-11 · accession 0001193125-25-318069 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-12 | 2025-12-11 | AARD | Lee Tien-Li | CEO, Dir, 10% | P - Purchase | $14.49 | +7,000 | 1.55M | +0.5% | +$101.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-11 | P | A | 7,000 | $14.49 | 1,551,613 | D | — | — |